期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

乳腺癌放化疗后并发治疗相关性急性单核细胞白血病1例报告并文献复习

原文传递
导出
摘要 乳腺癌是女性常见肿瘤之一，经手术联合放化疗综合治疗，患者生存率显著延长，5年生存率达80％，但由于放化疗损伤正常造血干细胞及免疫细胞，而导致基因突变，故治疗相关性白血病发病率逐年增多。我们报道1例乳腺癌放化疗后，并发治疗相关性急性髓性细胞白血病（t-AML）患者，并进行了文献复习。
作者 李芳 王颖
机构地区 山东省威海市文登中心医院检验科
出处 《中国实用医刊》 2014年第6期126-126,F0003,F0004,共3页 Chinese Journal of Practical Medicine
关键词 治疗相关性白血病 急性单核细胞白血病 文献复习 放化疗后 乳腺癌 并发 急性髓性细胞白血病 放化疗综合治疗
分类号 R737.9 [医药卫生—肿瘤]
  • 相关文献

参考文献15

  • 1展昭民,陈德发,吴红菊,贡铁军,任实,郝文鹏,唐庆华,关小军,张伯龙,马军.治疗相关性白血病的治疗[J].癌症进展,2005,3(2):106-109. 被引量：12
  • 2杨艺红,徐泽锋,张乃红,郝玉书,肖志坚.一例多发性骨髓瘤治疗相关性骨髓增生异常综合征[J].中华血液学杂志,2008,29(4):270-271. 被引量：9
  • 3Leone G, Pagano L, Ben-yehuda D, et al. Therapy-related leukemia and myIodysplasia : susceptibility and incidence [J]. Haematologica, 2007,92 (10) :1389-1398.
  • 4Smith SM, Le Beau MM, Huo D, et al. Clinical-cytogenetics associa- tions in 306 patients with therapy-related myelodysplastic and myeloid leukemis : the University of Chicago series [ J ]. Blood,2003,102 ( 1 ) : 43-52.
  • 5Leone G, Fianchi L, Pagano L, et al. Incidence and susceptibility to therapy-related myeloid neoplasms [ J ]. Chem Biol Interact, 2010, 184(1-2) :39-45.
  • 6McLaughlin P, Estey E, Glassman A, et al. Myelodysplastic and a- cute myeloid leukemia following therapy for indolent lymphoma with fludarabin, mitoxantrone, and dexmethasone ( FND ) plus rituximab and interferon alpha [ J ]. Blood, 2005,105 ( 4 ) :4573-4575.
  • 7Metaye C, Curtis RE, Vose J, et al. Myelodysplastic syndrome and acute myeloid leukemia afte autotransplantation for lymphoma: a mul- ticenter case-control[J]. Blood, 2003 ,101:2015-2023.
  • 8Mays AN, Osheroff N, Xiao Y, et al. Evidence for direct involvement of epiubicin in the formation of chomosomal translocations in t ( 15 ; 17 ) therapy-related acute promyelocytic leukemia [J]. Blood, 2010, 115(2) :326-360.
  • 9Seymour JF, Juneja SK, Campbell LJ, et al. Secondary acute mye- loid leukemia with inv(16) : report of two cases following paclitaxel- containing chemotherapy and review of the role of intensified ara-C therapy[J]. Leukemia, 1999,13( 11 ) :1735-1740.
  • 10See HT, Thomas DA, Bueso-Ramos C,et al. Secondary leukemia after treatment with paclitaxel and carboplatin in a patient with recur- rent ovarian cancer[ J]. Int J Gynecol Cancer, 2006,16 ( Suppl 1 ) : 236-240.

二级参考文献12

  • 1肖志坚.骨髓增生异常综合征的诊断和治疗认识现况[J].国际输血及血液学杂志,2007,30(1):1-4. 被引量：9
  • 2Amiel A, Yukla M, Yogev S, et al. Deletion of 5q31 and 7q31 in patients with stable melphalan-treated multiple myeloma. Cancer Genet Cytogenet, 2004, 152 : 84-87.
  • 3Ishii Y, Hsiaoa HH, Sashidaa G, et al. Derivative (1;7)(q10; p10) in multiple myeloma. A sign of therapy-related hidden myelodysplastic syndrome. Cancer Genet Cytogenet, 2006, 167: 131- 137.
  • 4Mauritzson N, Albin M, Rylander L, et al. Pooled analysis of clinical and cytogenetic features in treatment-related and de novo adult acute myeloid leukemia and myelodysplastic syndromes based on a consecutive series of 761 patients analyzed 1976-1993 and on 5098 unselected cases reported in the literature 1974-2001. Leukemia, 2002, 16: 2366-2378.
  • 5Rodjer S, Swolin B, Weinfeld A, et al. Cytogenetic abnormalities in acute leukemia complicating melphalan-treated multiple myeloma. Cancer Genet Cytogenet, 1990, 48 : 67-73.
  • 6Nilsson T, Nilsson L, Lenhoff S, et al. MDS/AML-associated cytogenetic abnormalities in multiple myeloma and monoclonal gammopathy of undetermined significance : evidence for frequent de novo occurrence and multipotent stem cell involvement of del(20q). Genes Chromosomes Cancer, 2004, 41 : 223-231.
  • 7[1]Rowley JD, Alimena G, Carson OM, et al A collaborative study of the relationship of the morphologyic type of acute nonlymphocytic leukemia with patient age and karyotype. Blood,1982 54:1013
  • 8[2]Valagussa P, Santoro A, Bellani F, et, al Absence of treatment-induced second neoplasms after ABVD in Hodgkin's disease. Blood, 1982, 59:488
  • 9[3]Lonizing Radiation-Levels and Effects: A report of the United Nations Scientific Committee on the Effects of Atomic Radiation.United Nations, New York, 1972
  • 10[4]Pedersen-Bjergaard J, et al. Translocation (3; 21) (q26;q22) in therapyrelated myelodysplasia following drugs targeting DNA-topoisomerase Ⅱ combined with alkylating agents andin myelopro-liferative disorders undergoing spontaneous leukmic transformation. Cancer Genet Cytogenet, 1994, 76:50

共引文献17

中国实用医刊
2014年 第6期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部